Autotransfusion Devices Market Report: Market Size & Forecast 2026

Autotransfusion devices, also called cell salvage systems, recover shed blood from the surgical or wound site, wash or filter it and return it to the patient. The market is valued at approximately $0.57 billion in 2025 and is forecast to grow at a 6.08% compound annual growth rate. North America leads in current revenue, while Asia-Pacific is the fastest-expanding region as hospital infrastructure and surgical capacity scale up.

• •Market size in 2025: about $0.57 billion.
• •Forecast CAGR: roughly 6.08% through the next 6-10 years.
• •North America is the largest region today; Asia-Pacific is growing the fastest.

A rising number of complex surgeries, including cardiac, orthopedic and trauma procedures, is generating more demand for intraoperative and postoperative blood salvage. Concerns over donor-blood shortages, transfusion-related infections and immune reactions are pushing hospitals to adopt patient blood management programs. An aging global population and higher rates of cardiovascular disease are also enlarging the pool of patients who can benefit from autotransfusion.

• •Increasing surgical and trauma caseloads worldwide.
• •Patient blood management initiatives aimed at reducing allogeneic transfusion.
• •Aging populations and higher prevalence of cardiovascular and orthopedic conditions.

The market is typically segmented by product type into intraoperative cell salvage devices, postoperative cell salvage devices and accessories/consumables, with intraoperative systems representing the largest share. End users are dominated by hospitals, followed by specialty cardiac and trauma centers and ambulatory surgical facilities. Geographically, North America and Europe together account for the bulk of revenue, while Asia-Pacific and parts of Latin America show the highest growth rates.

• •Product split: intraoperative, postoperative and consumables/accessories.
• •End users: hospitals, specialty surgical centers and ambulatory facilities.
• •Regional leaders: U.S., Germany, U.K., Japan and China.

What are the recent trends and outlook?

Recent product development is moving toward compact, automated cell-salvage units with shorter setup times and improved red blood cell recovery rates. Integration with electronic health records and hospital blood management IT platforms is becoming a selling point. Over the forecast period, the market is expected to benefit from wider adoption in trauma centers and obstetrics, alongside expansion into emerging healthcare markets.

• •Shift toward portable, automated and user-friendly devices.
• •Growing use of autotransfusion in trauma, obstetric and orthopedic settings.
• •Continued double-digit unit growth projected in Asia-Pacific through the late 2020s.